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Summary Surfactant protein-A enhances the phagocytosis and killing of many
pathogens, although studying this effect in an assortment of models and different
experimental protocols has sometimes yielded conflicting results. In this report,
using the human THP-1 cell line as the primary phagocytic cell, we systematically
examined several models where microspheres, Staphylococcus aureus and Escher-
ichia coli were used for targets. We found that SP-A derived from human lavage
appeared to enhance phagocytosis by two different mechanisms; by SP-A binding of
the target to enhance its recognition and subsequent phagocytosis and by a direct
SP-A stimulatory effect on the phagocyte itself. Both SP-A mechanisms occurred with
different targets in the same experimental system and the SP-A effects were
qualitatively (but not quantitatively) comparable in several human cell lines (THP-1,
U937, Mono-Mac-6). We also found that the SP-A effects were abrogated when SP-A
was combined with surfactant lipids, but the lipids did not affect the basal level of
phagocytosis or phagocytosis by mechanisms not involving SP-A. Moreover, the
stimulatory effect of SP-A was pH-dependent and appeared to be independent of
several other phagocytic mechanisms, including those mediated by Fc receptors and
mannose receptor.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Surfactant is a complex material that confers
mechanical stability to the distal lung and has a
role in the regulation of pulmonary host defense.1–3
It consists of approximately 90% lipids and 5–10%
protein. The best studied and most abundant of the
protein components is surfactant protein-A (SP-A),
a collagenous lectin or collectin. Other members of
the collectin family include SP-D, mannose binding
protein, conglutinin, and collectin-43.4 The com-
plement protein C1q has a structure similar to that
of mannose binding protein and SP-A, and although
it does not have a lectin or carbohydrate recogni-
tion domain (CRD), it is often grouped with the
collectins. SP-A is an oligomeric glycoprotein with a
monomeric molecular mass of 28–35 kDa. It is
synthesized and secreted by alveolar type II cells,
by cells of the tracheal and bronchial submucosal
glands, and in some species by nonciliated bronch-
iolar epithelial cells.5–8
The collectins, SP-A and SP-D, are thought to
play a variety of important roles in the defense of
the lung, including enhancing phagocytosis.1,3,4
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SP-A has been studied extensively. In vitro studies
have shown that SP-A can stimulate phagocytosis
and killing of various pathogens by alveolar macro-
phages, such as Escherichia coli, Staphylococus
aureus, Streptococcus pneumoniae and Haemophi-
lus influenzae.2,9–12 SP-A may exert these actions
by serving as an opsonin, by activating the macro-
phage directly, or by both of these mechan-
isms.10,13,14 It has been assumed that in most
cases the lectin or CRD of SP-A binds to glycocon-
jugates on the surface of the involved particle or
pathogen and that this binding enhances the
interaction between the particle or pathogen and
the cell surface of the phagocyte. SP-A has been
shown to bind a variety of ligands including: LPS,
lipoteichoic acid, peptidoglycan, lipids, glycolipids,
as well as a variety of carbohydrates,15–18 and these
interactions may mediate the SP-A effect on the
enhanced uptake of Gram negative bacteria, Gram
positive bacteria, viruses, fungi, pollen grains, and
some mineral particulates.1–3,9,14,19,20
Although in most studies the SP-A effect on
phagocytosis has been reported to be stimula-
tory,1,3,21 there is also evidence that in some
situations or with certain organisms SP-A does not
enhance phagocytosis.9,19,22,23 In previously pub-
lished studies a variety of experimental conditions,
assays, phagocytic cells, and species, as well as a
very broad assortment of microorganisms have
been used in different investigations. However,
the process of phagocytosis is complex and may be
affected by multiple factors.24–26 Examples of such
factors include: (a) the characteristics of the
phagocytic cells; such as their identity, degree of
activation, population of cell surface receptors,
and the local conditions with respect to pH and
ionic composition; (b) the characteristics of the
pathogen; including its identity, proliferation state,
and the nature of the pathogen-associated mole-
cular patterns (PAMPs) on its surface; (c) the nature
of other accessory molecules and opsonins avail-
able; including immunoglobulins, complement,
other opsonins (such as the mannose binding lectin)
and soluble receptors, including soluble forms of
the mannose receptor and CD14; (d) species-
specific mechanisms by which phagocytes kill
microorganisms.27,28 Therefore, this kind of com-
plexity underscores the need for caution in arriving
at conclusions about mechanisms involved in SP-A-
mediated phagocytosis.1–3
The purpose of the present study was to system-
atically examine the ability of human SP-A to
modulate phagocytosis in a human cell culture
system that would be: (a) free from problems
associated with the routine procurement of sam-
ples from human subjects; (b) employ a human cell
line and (c) eliminate potential problems due to
species differences. For example, a well-charac-
terized human cell culture system may overcome
issues relating to the limited number of cells
obtainable from volunteers, their heterogeneity
(even in the same individual), and potential
differences in both basal and stimulated levels of
activity in cells from different individuals. Although
some of the experimental variables examined here
have been examined previously by others, most
single studies examined a subset of the variables
we studied in this report making it difficult to
determine whether certain observations are cell- or
system-specific. In addition, nearly all of the
published work has used pooled rat alveolar
macrophages and human SP-A. Although cells from
rats may be more uniform than those from humans,
inter- and intra-individual variability as well as
species differences between rats and humans28 in
macrophage activity may be issues.
In the present study, we examined and compared
variables in a single system with the same assays
using human SP-A and the human THP-1 cell line as
the primary phagocytic cell. Following differentia-
tion with either phorbol myristate acetate (PMA) or
vitamin D3, THP-1 cells are actively phagocytic and
have many properties that resemble those of
macrophages. As targets for phagocytosis we used
fluorescent microspheres (beads) and two types
(one Gram negative and one Gram positive) of
fluorescently labeled bacteria. The use of micro-
spheres is advantageous and provides a simplified
model because it eliminates concerns about bac-
terial growth stage-dependent changes9 in surface
properties. Also, the use of this simplified model
eliminates concerns as to which of the multiple
different moieties on the bacterial surface (lipo-
polysaccharide (LPS), lipoteichoic acid, peptidogly-
can or other cell surface carbohydrates) are
mediating the binding of SP-A or of cell surface
molecules. Using these model systems we studied
phagocytosis with regard to molecules (i.e. recep-
tors) and/or pathways involved, as well as the
effect of pH and of surfactant lipids on phagocy-
tosis.
Materials and methods
Media and reagents
RPMI 1640 culture medium, L-glutamine, antibio-
tic–antimycotic solution (Penicillin G, streptomycin
sulfate, Amphotericin B), trypan blue, human
immunoglobulin G (IgG), mannose, and PMA were
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obtained from Sigma Chemical (St. Louis, MO) and
low-endotoxin fetal calf serum (FCS) was obtained
from BioWhittaker (Walkersville, MD). Paraformal-
dehyde was obtained from Ladd Research Industries
(Burlington, VT) and vitamin D3 from Biomol (Ply-
mouth Meeting, PA). Survanta (beractant intratra-
cheal suspension; Ross Products Division, Abbott
Laboratories, Columbus, OH) was used as a source
of surfactant lipid. Survanta is a preparation
derived from cow lung homogenate. It consists of
more than 95% lipids with a small amount of the
hydrophobic surfactant proteins, SP-B and SP-C.
Survanta contains no SP-A. Fluorescent carboxy-
late-modified polystyrene microspheres or beads
(FluoSpheress), the fluorescently labeled bacteria
and the specific antibodies to them used in some
studies, and fluorescein-5-isothiocyanate, isomer I
(FITC) were purchased from Molecular Probes Inc.,
Eugene OR).
Isolation of SP-A
SP-A was prepared from alveolar proteinosis lavage
by two methods to eliminate concerns that SP-A
effect was an artifact of a specific preparation
procedure. The protein preparations obtained by
these two methods displayed nearly identical
properties in the assays utilized here. In one
method we used preparative isoelectric focusing
(Rotofor, Bio-Rad, Hercules, CA) to purify SP-A. This
method has been thoroughly described else-
where.29 Butanol extraction of the same alveolar
proteinosis lavage material was also used to
prepare SP-A. This method has been described in
detail.30 All of the data presented in this report
were obtained with SP-A obtained via butanol
extraction, although SP-A prepared by isoelectric
focusing gave the same results (data not shown).
The purified protein from these methods was
examined by two-dimensional gel electrophoresis
and silver staining and found to be greater than 99%
pure. The content of endotoxin was determined
with the QCL-1000 LAL assay (BioWhittaker, Walk-
ersville, MD). This test indicated an average
endotoxin content of less than 3 pg LPS/mg SP-A.
SP-A was stored at a concentration 1mg/ml in
Hank’s Balanced Salt Solution (pH 7.4) at –801C.
Although all of the data presented in this report
were prepared with SP-A isolated from a single
alveolar proteinosis patient, we performed some
experiments with SP-A isolated from at least three
other alveolar proteinosis cases, normal human
lung lavage, and with SP-A from an in vitro
expression system.29,31
Cell culture
The THP-1 and U937 cell lines and S. aureus 25923
and E. coli were obtained from the American Type
Culture Collection (ATCC; Manassas, VA). Mono-
Mac-6 cells were obtained from the German
Collection of Microorganisms and Cell Cultures
(Braunschweig, Germany). The THP-1 cells were
cultured in complete RPMI 1640 with 0.05mM 2-
mercaptoethanol as recommended by the ATCC and
10% heat-inactivated (2 h, 561C) FCS. The same
culture medium without mercaptoethanol was used
for U937 cells. Mono-Mac-6 cells were grown in
RPMI1640 medium with 10% FCS supplemented with
non-essential amino acids and sodium pyruvate.
Cells were grown in suspension in 75 or 175-cm2
tissue culture flasks and subcultured periodically to
maintain a cellular density of 5 105 cells/ml.
Because the properties of the THP-1 cell can
change dramatically after prolonged periods in
culture, cells were discarded after 15 passages
and replaced by fresh stocks that had been placed
in frozen storage shortly after being obtained from
the supplier. The other cell lines were treated
similarly. THP-1 cells were differentiated for 72 h
by 10–8 M vitamin D3 or 24 h by 10
–8 M PMA. Both
methods have been well-characterized and the
phagocytic properties appear to be roughly equiva-
lent with either method. However, the cells are
adherent after PMA treatment so PMA differentia-
tion was the method of choice for the plate
fluorometer assay and vitamin D3 treatment, where
the cells remained in suspension, was used for most
FACS experiments. After each incubation period,
cells were counted using a hemocytometer, and
viability was assessed by trypan blue exclusion. The
cell suspensions were 495% viable.
Labeling of bacteria by fluorescein
isothiocyanate (FITC)
S. aureus and E. coli from log phase cultures (4 h
incubation) were collected by centrifugation at
3000 rpm for 10min and washed with 50ml phos-
phate-buffered saline (PBS). The bacteria were
heat-killed in a water bath at 951C for 10min and
were resuspended in 10ml of 0.1M sodium carbo-
nate buffer (pH 9.0) at a density of 4.5 109 bac-
bacteria/ml. Fluorescein isothiocyanate (FITC)
from a 10mg/ml stock solution in dimethyl sulf-
oxide (DMSO) was added to a final concentration of
0.175mg/ml. Bacterial labeling was done for 1 h at
room temperature with continuous shaking while
protected from light. The bacteria were subse-
quently centrifuged at 2000 g for 10min and
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washed with 50ml PBS three times or until the
supernatant was clear. Bacteria were resuspended
in RPMI 1640 without FCS to a final concentration of
1 109/ml by determining optical density at 660nm
in a spectrophotometer. Aliquots of 1ml of bacterial
suspension were placed in microcentrifuge tubes,
dried by lyophilization and stored at –201C.
SP-A enhanced phagocytosis measured by
flow cytometry
Vitamin D3-differentiated THP-1 cells were washed
once with PBS and resuspended in fresh serum-free
RPMI1640 at a density of 1 106 cells/ml. Some
experiments were also done with U937 and Mono-
Mac-6 cells under identical conditions. Micro-
spheres were prewashed then diluted with serum-
free RPMI1640 at a density of 2.5 109 beads/ml.
The ratio of microspheres to THP-1 cells was 50:1 in
each experiment. Microspheres were vortexed for
several seconds before experiments. For some
experiments microspheres were preincubated with
25 mg/ml SP-A for 15min at 371C, washed three
times with serum-free RPMI1640, then added to the
THP-1 cells. Microspheres without SP-A served as a
control. At given intervals cells were harvested and
unbound microspheres washed away with PBS.
These experiments were performed in the absence
and in the presence of serum and comparable results
were obtained under both conditions (data not
shown), although the magnitude of the cell-asso-
ciated fluorescence in the presence of serum was
greater. However, in the absence of serum the THP-1
cells became increasingly adherent, complicating
analysis by FACS. To overcome adherence problems
we reduced serum concentrations from 10% to 0.5%
(which we used in these experiments) with little
effect on the amount of cell-associated fluorescence
under a given set of conditions (data not shown).
Cells were fixed with freshly prepared 1%
paraformaldehyde on ice for 30min in the dark
and then each sample washed three times with
wash-buffer (PBS, 1% bovine serum albumin, 0.02%
sodium azide). Samples were resuspended in wash
buffer and kept in the dark at 41C until FACS was
performed. Because the fluorescent label on the
microspheres is within the matrix of the bead as
well as on its surface, it is not possible to quench
their fluorescence completely in order to distin-
guish between externally bound and internalized
microspheres. However, in the bacterial studies
described later we were able to describe phagocy-
tosis because we could distinguish between parti-
cles bound to the phagocytic cell surface and those
that had been internalized by quenching the
external fluorescence with trypan blue. Therefore,
in the microsphere experiments cell-associated
fluorescence is referred to simply as cell-associated
fluorescence or binding, whereas in the bacterial
experiments we refer to total fluorescence as cell-
associated fluorescence and the fluorescence that
remains after trypan blue treatment is taken to
represent internalization and is referred to as
phagocytosis.
SP-A enhanced phagocytosis using a plate
microfluorometric assay
THP-1 cells were differentiated for 24 h by 10–8 M
PMA in black Costar clear-bottom 96 well plates.
Each well contained 200 ml of medium with THP-1
cells at a density of 1 106 cells/ml. After differ-
entiation, the cells were washed with PBS and the
medium replaced with serum-free RPMI1640. E. coli
K-12 or S. aureus 25923 were preincubated with
25 mg/ml SP-A for 15minutes at 371C in serum-free
RPMI1640. The SP-A bound bacteria were washed to
remove unbound SP-A and resuspended in serum-
free RPMI1640 at a final density of 1 108 bacteria/
ml or a 100:1 bacteria:cell ratio. Binding of the SP-
A directly to the bacteria was confirmed by eluting
the washed bacteria with SDS sample buffer,
running the eluted proteins on SDS gels, and
immunostaining with an SP-A antibody (data not
shown).32 At the conclusion of each experiment
phagocytosis was stopped by the addition of ice
cold PBS and unbound bacteria washed away. The
fluorescence in each well was measured at an
excitation wavelength of 485 nm and an emission
wavelength of 530 nm using a 7630 Microplate
Fluorometer (Cambridge Technology, Inc.). The
plate fluorometric assay requires the use of fewer
cells and smaller quantities of stimulatory or
modulating agents and allows us to test many more
conditions at a time than the FACS-based assays do.
For the plate assay, PMA-differentiated THP-1 cells
were used, because PMA-differentiated THP-1 cells
are adherent to a microtiter plate. All incubations
and washes were done in the plate, including the
incubation with trypan blue to quench external
fluorescence, which allows for measurement of
internalized fluorescence or phagocytosis.
Trypan blue treatment
After an initial fluorometric reading, 200 ml of
trypan blue (0.25mg/ml, pH 4.4) was added to
each sample to quench the external fluorescence,
and the plate was read again to measure the
amount of internalized fluorescence.
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Flow cytometry
Flow cytometric analyses were performed with a
FACScan (Becton Dickinson Mountain View, CA).
Relative fluorescence was measured in 1 104 cells
per sample. Data were acquired and processed
using the Cellquest software Cell Quest Version 3.1f
or FACS Analysis WinMDI Version 2.8.
Statistical analysis
Data were analyzed using SigmaStat (SPSS Inc.,
Chicago, IL) with a Po0.05 considered significant.
In most cases statistical comparisons were made
using a one way analysis of variance (ANOVA) with
the Bonferroni correction for multiple comparisons
with a Po0.05 considered significant. In time
course experiments experimental points were
compared with controls at the same time point
using a t-test. Differences between experimental
values and control points were considered signifi-
cant when Po0.05.
Results
Binding of microspheres
The first series of experiments was done to assess
the role of SP-A in phagocytosis using fluorescent
microspheres. Cell-associated fluorescence was
quantified by FACS analysis and included both
externally bound and internalized microspheres.
We first performed a time course experiment in
which SP-A (25 mg/ml) and the fluorescent micro-
spheres were added to the THP-1 cells for time
periods ranging from 30min to 3 h (Fig. 1). The
difference between SP-A enhanced binding and
controls continued to increase for the duration of
the experiment. However, we selected the 2 h time
point to conduct a dose response study using doses
of SP-A ranging from 5 to 50 mg/ml (Fig. 2) for most
of our studies. Although there was a dose-depen-
dent increase in SP-A-stimulated binding through-
out the tested concentrations, we used a dose of
25 mg/ml in subsequent studies because this re-
sulted in a less than maximal effect so that both
stimulatory and inhibitory influences could be
detected in other experiments.
Role of surfactant lipids
In this series of experiments, lipid (in the form of
Survanta) was preincubated with SP-A (25 mg/ml)
for 30min at 371C and the mixture added to the
THP-1 cells at the same time as the microspheres. In
negative control samples only SP-A or only micro-
spheres were added to the THP-1 cells. Doses of lipid
ranging from 1000mg/ml down to 50mg/ml caused a
reduction in phagocytosis from levels that would
have been seen if the SP-A was added alone.
However, at lipid concentrations below 200mg/ml
stimulation over control levels was still evident
(Fig. 3). At the highest dose of lipids (1000mg/ml)
levels of cell-associated fluorescence were equiva-
lent to those seen in the absence of SP-A, suggesting
that the lipid affected only the SP-A mediated
stimulation and not basal levels of cell-associated
fluorescence (binding and internalization).
SP-A as an opsonin or an activation ligand
We used several different conditions for incubation
of SP-A with the microspheres and the THP-1 cells.
As shown in Fig. 4, the control for these experi-
ments was cells incubated with microspheres alone
(group 1). We preincubated microspheres for
15min at 371C in SP-A (25 mg/ml), removed un-
bound SP-A by washing and centrifugation of the
microspheres and then added the SP-A preincu-
bated microspheres to THP-1 cells (group 2). In
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Figure 1 Time course of SP-A enhancement of cell-
associated fluorescence. Fluorescent microspheres
(beads) were added to THP-1 cells in the presence or
absence of 25 mg/ml of SP-A and the incubation continued
for the specified intervals. Relative fluorescence was
measured by FACS in cells incubated with both micro-
spheres and SP-A, compared to cells incubated with
microspheres alone, and to cells not exposed to micro-
spheres. The ratio of microspheres to THP-1 cells was
50:1. A representative experiment in which all points
were done in triplicate is shown. The mean value7SEM is
depicted and an asterisk (*) indicates that the SP-A-
treated samples were significantly different (Po0.05) at
the indicated time point.
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parallel we used microsphere suspensions that were
preincubated without washing away any unbound
SP-A (group 4). We also added microspheres and SP-
A simultaneously to THP-1 cells (no preincubation,
group 3). In this series of experiments, we found
that SP-A is capable of increasing cell-associated
fluorescence in all cases (Fig. 4). However, the
greatest effect was seen in cases where the target
microspheres were preincubated with SP-A and the
unbound SP-A remained in the incubation medium
(group 4, Fig. 4). Moreover, in group 4 the effects of
SP-A appeared to be additive of those in groups 2
and 3. In the studies reported here, the SP-A
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Figure 3 Dose-dependent effects of surfactant lipids on
SP-A enhanced binding. Microspheres were incubated in
25 mg/ml of SP-A with or without surfactant lipid
(Survanta) at the indicated concentration for 30min at
371C. The microspheres and SP-A þ /– lipid were then
added to THP-1 cells and the incubation continued for
2 h. Controls (shown in bars) include cells incubated with
beads only, and cells incubated without beads but with
SP-A alone, Survanta alone, and a combination of SP-A
and Survanta. Relative fluorescence of triplicate points
(mean7SEM) was determined by FACS from a representa-
tive experiment. The points in which Survanta was
present were compared to the point in which 25 mg/ml
of SP-A and no Survanta was used. Points where a
significant (Po0.05) inhibition was seen are indicated
(* ).
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Figure 4 Comparison of preincubation and simultaneous addition of SP-A and microspheres. THP-1 cells were
incubated with microspheres (beads) for 2 h and then analyzed by FACS (group 1). Microspheres were preincubated with
25 mg/ml of SP-A for 15min at 371C and either washed (group 2) to remove unbound SP-A and transferred to the THP-1
cells or transferred without washing (group 4). An additional series consisted of cells to which microspheres and SP-A
were added simultaneously (no preincubation; group 3). The mean 7SEM for a representative experiment are shown.
Using group 1 as the control, statistically significant (Po0.05) points are indicated (*).
SP-A  (µg/ml)
0 10 20 30 40 50
R
el
at
iv
e
 
Fl
u
o
re
s
c
en
c
e
0
50
100
150
200
Co
n
tr
o
l, 
c
el
ls
 
o
n
ly
SP
-A
; n
o
 b
ea
ds
*
*
*
Figure 2 SP-A dose response curve and binding of
microspheres. Fluorescent microspheres were preincu-
bated with SP-A at concentrations from 0 to 50 mg/ml for
15min at 371C. The microspheres were then washed and
incubated with THP-1 cells for 2 h. Relative fluorescence
was determined by FACS. Control samples consisted of:
(a) cells that were not incubated with microspheres; (b)
the sample labeled ‘‘SP-A; no beads’’ where the
fluorescence was measured in cells that were exposed
to SP-A only and not to microspheres and; (c) the 0 mg/ml
SP-A point which was used as the control for statistical
comparisons. The figure depicts a representative experi-
ment and all points were done in triplicate. The mean
7SEM is shown and points marked with an asterisk (*)
were significantly different (Po0.05) from the control
(0 mg/ml SP-A) point.
642 J. Ding et al.
concentration mixed with the microspheres was
25 mg/ml. Although we did not measure the relative
amounts of microsphere-bound SP-A and ‘‘free’’ SP-
A in these experiments we have shown in previous
publications that SP-A can enhance TNF-a levels or
activation of NF-kB within 1 h at doses or 10 mg/ml
or less.29,33 A similar effect of SP-A on activation of
macrophages, in addition to its opsonic role, has
been demonstrated in macrophages from SP-A–/–
mice.34
Phagocytosis of bacteria
The next series of experiments was done to assess
the role of SP-A in the binding and uptake of certain
bacteria. The bacteria were labeled with FITC and
binding and phagocytosis were assessed using two
different methods, the FACS method used in the
fluorescent microsphere experiments, and a plate
fluorometric assay. The first set of experiments was
a time course study using bacteria that were
preincubated in 25 mg/ml of SP-A, as we used in
most of the microsphere experiments. We per-
formed experiments with both S. aureus (Fig. 5)
and E. coli (Fig. 6). In time points ranging from
15min to 3 h we found that SP-A enhanced both the
total THP-1 cell-associated fluorescence (Figs. 5A
and 6A) and the internalized fluorescence mea-
sured after trypan blue quenching of external
fluorescence (Figs. 5B and 6B). SP-A dose response
studies with both types of bacteria using SP-A doses
of 2.5–100 mg/ml, were performed using FACS
(not shown) and the results were equivalent
to those obtained with the plate fluorometric
assay. We chose an SP-A dose of 25 mg/ml for
subsequent studies (as we did with the fluorescent
microsphere studies). The data from these experi-
ments (a) confirm previous studies of binding
and phagocytosis of bacteria, (b) indicate that
the stimulatory effect of SP-A can occur with
both bacteria and microspheres, and (c) show
that in the bacterial studies the stimulatory effect
was on both binding to the cell surface and
internalization.
SP-A effects on phagocytosis by other
monocytic cell lines
To assess cell specificity, we did a series of
comparison studies in which, in addition to the
THP-1 cell line, we used two other cell lines, U937
cells and Mono-Mac-6 cells (Fig. 7). Published
studies with these monocytic cell lines have used
a variety of conditions, including no additional
differentiation step, differentiation with either
PMA or vitamin D3, or with other substances.
35–38
We used differentiated cells for these studies.
Furthermore, we examined the SP-A effect in the
presence of 0.5% FCS and in the absence of serum.
In all cases the background fluorescence was
roughly equivalent, but control (no SP-A) levels of
phagocytosis of labeled S. aureus, while nearly
identical in U937 and Mono-Mac-6, were approxi-
mately twice as high in THP-1 cells (hatched bar) in
both the presence and the absence of serum
(Fig. 7). When the bacteria were preincubated in
25 mg/ml of SP-A and washed before addition to the
cells, increased levels of cell-associated fluores-
cence were seen in all cases. However, there were
much greater increases when SP-A and the bacteria
were added simultaneously to the cells. This finding
was similar to that seen in the microsphere
experiments (Fig. 4). These data indicate that
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Figure 5 SP-A effect on phagocytosis of S. aureus in
plate fluorometric assay. FITC-labeled S. aureus was
preincubated with 25 mg/ml of SP-A for 15min at 371C
and then added to THP-1 cells in 96-well plates. S. aureus
that was not preincubated with SP-A served as a control.
After incubating for the indicated time period, unbound
bacteria were removed by washing and cell-associated
fluorescence was measured with a plate fluorometer
(Panel A). Trypan blue was then added to quench external
fluorescence and the plate was read again to measure
internalized fluorescence (Panel B). At all points the
mean 7SEM is shown. At each time point the sample with
SP-A is compared to the corresponding sample with no
SP-A. Significant (Po0.05) differences are indicated (* ).
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although the general properties of these cell lines
are similar, the magnitude of response differs
among them.
Opsonization with SP-A versus specific
antibody
To assess whether SP-A could affect phagocytosis of
bacteria mediated by the binding of the immuno-
globulin in an E. coli specific antibody to Fc
receptors directly or indirectly through activation
of the macrophage we did the following set of
experiments (Fig. 8). As described above, when we
preincubated E. coli with SP-A and washed away
unbound SP-A we observed an approximate 2-fold
increase in phagocytosis (group 3) versus unopso-
nized bacteria (group 2). As expected, further
increases occurred when we did not wash away
unbound SP-A after preincubation (group 4) or
when we added SP-A and E. coli simultaneously to
the THP-1 cells (group 5). These groups were
analyzed statistically by ANOVA with the Bonferroni
correction and the results are indicated in column
D. We also compared the same set of samples
(column C) by designating the SP-A pre-incubation
and wash group (group 3) as the control sample and
comparing it to the samples where there was no
washing to remove unbound SP-A (groups 4 and 5).
Both of these groups had significantly higher
binding than group 3, where unbound SP-A was
washed away. All of the incubations including
antibody (groups 6–8) were significantly increased
over those of E. coli alone (group 2) (column B).
However, although the degree of phagocytosis of
antibody-opsonized (preincubated) E. coli (group 6)
was significantly greater than that with E. coli
alone (group 2). Moreover, if the antibody-opso-
nized bacteria were also preincubated with SP-A
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Figure 7 Phagocytosis of S. aureus by several monocytic cell lines. FITC-labeled S. aureus either alone, following a
15min preincubation with 25 mg/ml of SP-A, or with 25 mg/ml of SP-A (no preincubation) was added to cultures of THP-1
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Figure 6 SP-A effect on phagocytosis of E. coli in plate
fluorometric assay. This experiment was identical to that
in Fig. 5, but E. coli was used. At all points the mean7SEM
is shown. At each time point the sample with SP-A is
compared to the corresponding sample with no SP-A.
Significant (Po0.05) differences are indicated (* ).
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(group 7) or if SP-A was added when the bacteria
were added to the cells (group 8), no significant
change in cell-associated fluorescence was seen in
these cells versus cells incubated with E. coli with
antibody alone (group 6) (column A). This suggests
that Fc-receptor mediated phagocytosis was not
affected by either the activation of the THP-1 cells
resulting from SP-A in the medium (group 8) not
bound to the bacteria, or by SP-A bound to the
bacteria during pre-incubation (group 7). However
with both of these types of SP-A treatments levels
of binding and phagocytosis of bacteria increase
(Fig. 8, groups 4 and 5; Fig. 4, groups 3 and 4).
Role of other factors in SP-A induced binding
To determine whether receptors known to be
involved in phagocytosis are also involved in the
SP-A response observed in the system under study,
we attempted to reduce the number of available
receptors by preincubating THP-1 cells in several
ligands for these receptors (Fig. 9). The conditions
we employed have been used in studies published
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Figure 9 Time course of binding after preincubation of
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by other investigators investigating these recep-
tors. We used 50 mg/ml of human IgG to react with
Fc receptors and 10mg/ml of mannose to compete
with binding by the mannose receptor.39 We chose
microspheres as a target for these studies because
of their simplicity, since they are devoid of
molecules and potential ligands for phagocytic
receptors that are present on bacteria. Neither of
these had much of an effect on SP-A activity. We
also examined the effect of pH on the SP-A
stimulation of binding of microspheres. Using
medium at pH 7.5, 6.5, and 5.5 we found that the
SP-A effect decreased as the pH decreased (Fig.
10). The pH of the alveolar hypophase under
normal conditions is thought to be 6.9.40
Discussion
Phagocytosis in the lung occurs through a variety of
diverse processes that effectively clear different
targets, including particles, pathogens, and apop-
totic cells, from the alveolar spaces. Different cell
surface receptors on the phagocytic cells can
recognize diverse components on the targets
directly or via host-derived adapter molecules that
bind to different surface components.24–26 These
receptors may include Fc receptors, mannose
receptors, and complement C1q receptors, all of
which have been demonstrated to be expressed on
THP-1 cells.41–43 Interaction between these micro-
bial surface components and the receptors on the
phagocytic cells results in binding of the target by
the phagocytic cell, followed by its internalization.
The events following internalization are also
diverse.24–26 Adding to the complexity of phagocy-
tosis is the fact that some or all of these processes
can be altered depending on the recent activities
of the cell or changes in its microenvironment.
Therefore, in this study we examined, in a
systematic way, the role of SP-A in phagocytosis
and tried to gain insight into the molecules and
factors involved by studying multiple targets and
receptors in a single human cell type with the same
experimental protocols. We studied interactions of
SP-A (prepared by two different methods) with
polystyrene microspheres to eliminate concerns
about the growth stage of the bacteria or the
method of sample preparation. We believe that the
amounts of SP-A we have used in our studies are
within physiological ranges. This is based on several
assumptions that have been made by various
laboratories. BAL levels of SP-A in normal indivi-
duals are estimated to be in the range of 2–10 mg/
ml and are likely to have been diluted 10–100 fold
by the lavage procedure.44,45 However, in the
normal lung, 95% of this SP-A is thought to be
lipid-associated and probably inactive in terms of
influencing phagocytic events.46,47 The amount of
SP-A is about 2–5% that of the surfactant lipids so
the amounts of lipid added are also within
physiological ranges.
We also studied: (a) two kinds of bacteria; S.
aureus, as a representative Gram positive bacter-
ium, and E. coli as a representative Gram negative
bacterium; (b) different monocytic cell lines for
cell specificity and as models of phagocytic cells;
(c) the role of known receptors and other factors in
SP-A mediated phagocytosis; (d) the effect of
surfactant lipid on the basal level of cell/target
binding and SP-A-enhanced binding. The results
showed that in all cases SP-A bound directly to the
target (microsphere or bacterium) and also suggest
that an interaction occurred between SP-A and the
phagocytic cells themselves. The data from these
experiments: (a) confirm previous studies of bind-
ing and phagocytosis of bacteria; (b) indicate that
the stimulatory effect of SP-A can occur with both
bacteria and microspheres; (c) show that in the
bacterial studies the SP-A stimulatory effect was on
both bacterial binding to the cell surface and
internalization of bacteria; and (d) suggest that
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Figure 10 pH dependency of SP-A effects on cell-
associated fluorescence. SP-A was preincubated with
fluorescent microspheres for 15min at 371C in buffer at
either pH 5.5, 6.5, or 7.5. The microspheres were then
washed and added to THP-1 cells. After incubation for
intervals from 30min to 3 h FACS was used to quantify
cell-associated fluorescence. Values from a representa-
tive experiment (mean 7SEM) are depicted. The pH 7.5
samples were used as controls and comparison made at
each time point. Significant differences are indicated (* ).
646 J. Ding et al.
enhancement of phagocytosis by SP-A can occur
whether SP-A is bound to Gram negative bacteria,
presumably by LPS, or to Gram positive bacteria,15
where the interaction is probably with lipoteichoic
acid.18 It is important to note that although we saw
positive effects on both types of bacteria used
here, variable effects have been noted in other
studies depending upon the growth stage of a
specific strain of bacteria strain9 or different
strains of the same bacteria.15,48 There have also
been reports of pathogens whose clearance is not
affected by SP-A.19,22,23
The SP-A mediated effect appeared to be
sensitive to pH changes, and Fc or mannose
receptors were not the primary mediators in this
system as has been reported in other systems.49
Moreover, the SP-A mediated effects were qualita-
tively the same in several different human mono-
cytic cell lines, although quantitative differences
were observed. Furthermore, the surfactant lipids
inhibited SP-A-induced binding of targets without
affecting basal levels. The precise underlying
mechanisms are not known but the process is rapid,
being apparent as early as 30min after addition of
SP-A or an SP-A-coated target particle, as are many
other SP-A actions.1 The rapidity of the effect
suggests that the stimulatory effect is probably the
result of new protein or RNA synthesis or due to the
secretion or action of cytokines.
With both types of bacteria and with the micro-
spheres there was an SP-A dose-dependent en-
hancement of binding by the THP-1 cells including,
at least in the case of the bacteria, both cell
surface binding and internalization. However, much
of this effect was negated in the presence of added
surfactant lipid, although surfactant lipid addition
had no impact on basal levels of binding, indicating
that the inhibitory effect of surfactant lipid on SP-
A-mediated events is specific to SP-A. Surfactant
lipids have been shown to abrogate other SP-A
effects,1 including activation of NF-kB,33 modula-
tion of cytokine production,50–52 cell surface
marker expression,53 and immune cell prolifera-
tion51 and fibroblast function.54 Furthermore, the
surfactant lipid effect on cytokine production by
THP-1 following treatment with factors other than
SP-A alone, was to a lesser extent than that
observed following treatment with SP-A55 or with
SP-A and bleomycin.50 Presumably, the lipid and SP-
A combine to form surfactant lipoprotein com-
plexes and the complexed SP-A is then unable to
interact with the target particle. This observation
raises some question about the importance of the
SP-A effect on phagocytosis in normal lung, where,
as mentioned above, more than 95% of the SP-A is
thought to be complexed with lipid. However, this
could indicate that the SP-A effects on phagocytosis
become more important in the lung when there are
alterations in surfactant composition, particularly
if the amount of SP-A is increased.45
The increased susceptibility of SP-A null mice to
infection with several microorganisms seems to
reaffirm the importance of SP-A in the clearance of
these organisms from the lung.56 But SP-A exerts
multiple effects on phagocytic cells, including
effects on levels of activity and cell surface
molecule expression, as well as on chemotaxis
and oxygen radical production 34,57 so it is difficult
to distinguish whether the increased susceptibility
to infection is directly or indirectly due to the
absence of SP-A. For example, the increased
susceptibility may be due to the deficiency in the
ability of the macrophage to clear bacteria;
perhaps a consequence of deficient macrophage-
priming by SP-A, as would be the case in the SP-A
–/– mouse but not in the wild type. In fact,
macrophages from the SP-A knockout mouse exhibit
decreased macrophage function including bacterial
killing and reactive oxidant generation.34,57 An-
other reason for the decreased macrophage func-
tion in the SP-A knockout mice may be the lack of
the normal stimulatory influence exerted by SP-A
on the expression of cell surface markers.53
The SP-A effect does not appear to be cell line
specific as assessed by the results from the three
different monocytic cell lines, the THP-1 line, the
U937 line, and the Mono-Mac-6 line, used here.
However, differences in the magnitude of the
response were observed. Many studies involving
these cells employ vitamin D3, phorbol myristate
acetate, or some other agent to further differenti-
ate the cells.36,38,58 We found that the phagocytic
behavior of all three lines was similar and that
differentiation with vitamin D3, while slightly
increasing the amount of phagocytosis, had no
effect on the nature of the response. In this context
the role of serum proteins on the SP-A effect
appeared to affect the magnitude of the response
(greater in the presence of serum), but not the
quality of the response (i.e. the response pattern).
The generalized increases in the presence of serum
suggest a non-specific activation of the cells, rather
than a specific interaction with SP-A, and that
addition of SP-A enhances the process of phagocy-
tosis.
Other investigators have implicated various
receptors in mediating the SP-A effect, such as
the SP-A receptor,59 the mannose receptor 49 or the
C1q receptor.60,61 ‘‘The present study assessed the
potential interaction of the SP-A-specific mechan-
ism with other phagocytic mechanisms. There did
not appear to be any change in the SP-A-mediated
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effect after modulating the activity of mannose
receptors and Fc receptors, suggesting that these
receptors do not play a role in the enhancement of
phagocytosis by SP-A in this system.’’
There was also no evidence that the activation
effect of SP-A had any influence on antibody-
mediated phagocytosis. Therefore, the SP-A
mediated effects in the THP-1 cell culture system
may be occurring via an SP-A receptor or by other
pattern recognition receptors involved in innate
immune processes. Evidence has been published
that SP-A can interact with Toll-like receptors.62,63
The presence of an SP-A receptor has not been
documented in all of the cells used here, although
it is expressed in the U937 cell line.64 Alternatively,
SP-A may interact with other cell surface molecules
that have not yet been identified. Moreover,
because the SP-A effect was diminished at acidic
pH, it is possible that pH changes in the local
environment, as may occur in some disease states,
may compromise phagocytosis and further contri-
bute to disease progression.
In summary, we systemically examined the ability
of SP-A to modulate phagocytosis in a human cell
culture system. In this system; (a) SP-A was found
to exert similar stimulatory effects on the binding
and internalization of fluorescent microspheres,
Gram positive and Gram negative bacteria both by
enhancing the recognition of these targets by
phagocytic cells, and by exerting a direct stimula-
tory effect on these cells. (b) Comparable findings
were observed for other cell lines used as phagocytic
cells, although the THP-1 cell line showed higher
levels in certain cases. (c) Surfactant lipids abro-
gated the SP-A enhanced effect on phagocytosis but
had no effect on basal levels. (d) Under the
conditions employed here the SP-A-mediated effects
were sensitive to pH changes and specific to SP-A
rather than to an enhancement of other known
phagocytic mechanisms involving Fc or mannose
receptors, although there does seem to be an
interaction between SP-A and the C1q receptor.
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